Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Correspondence:
View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Limdi, N. A.
Right arrow Articles by Burneo, J. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Limdi, N. A.
Right arrow Articles by Burneo, J. G.
Related Collections
Right arrow Status epilepticus
Right arrow All Epilepsy/Seizures
Right arrow Antiepileptic drugs
Right arrowRelated Article
NEUROLOGY 2005;64:353-355
© 2005 American Academy of Neurology
Brief Communications

Efficacy of rapid IV administration of valproic acid for status epilepticus

N. A. Limdi, PharmD, A. V. Shimpi, MD, E. Faught, MD, C. R. Gomez, MD and J. G. Burneo, MD, MSPH

From the University of Alabama School of Medicine (Drs. Limdi, Shimpo, and Faught), Birmingham, AL; Brookwood Hospital (Dr. Gomez), Birmingham, AL; Epilepsy Program (Dr. Burneo), University of Western Ontario, London Health Sciences Center, London, Ontario, Canada.

Address correspondence and reprint requests to Dr. Nita Limdi, UAB Epilepsy Center, Civitan International Research Center, Room 312, 1719 6th Avenue South, Birmingham, AL 35294-0021; e-mail: nlimdi{at}uab.edu

Although not approved by the US Food and Drug Administration for the treatment of status epilepticus (SE), valproic acid (VPA) is an emerging option for this purpose. The authors reviewed 63 patients (30 men) with SE treated with IV VPA (average dose, 31.5 mg/kg). Analysis of demographic, clinical, and treatment information indicated an overall efficacy of 63.3% and favorable tolerance of rapid administration.

Received March 8, 2004. Accepted in final form September 7, 2004.


Related Article

January 25 Highlights
Neurology 2005 64: 180-181. [Full Text] [PDF]



This article has been cited by other articles:


Home page
 J. Neurol. Neurosurg. PsychiatryHome page
G Moddel, S Bunten, C Dobis, S Kovac, M Dogan, M Fischera, R Dziewas, W-R Schabitz, S Evers, and S Happe
Intravenous levetiracetam: a new treatment alternative for refractory status epilepticus
J. Neurol. Neurosurg. Psychiatry, June 1, 2009; 80(6): 689 - 692.
[Abstract] [Full Text] [PDF]

Home page
 JAOA: Journal of the American Osteopathic AssociationHome page
R. Behrouz, S. Chen, and W. O. Tatum IV
Evaluation and Management of Status Epilepticus in the Neurological Intensive Care Unit
J Am Osteopath Assoc, April 1, 2009; 109(4): 237 - 245.
[Abstract] [Full Text] [PDF]

Home page
 Therapeutic Advances in Neurological DisordersHome page
F. Rosenow and S. Knake
Review: Recent and future advances in the treatment of status epilepticus
Therapeutic Advances in Neurological Disorders, July 1, 2008; 1(1): 25 - 32.
[Abstract] [PDF]

Home page
 Nephrol Dial TransplantHome page
K. El Karoui, M. Le Quintrec, E. Dekeyser, A. Servais, A. Hummel, F. Fadel, and F. Fakhouri
Posterior reversible encephalopathy syndrome in systemic lupus erythematosus
Nephrol. Dial. Transplant., February 1, 2008; 23(2): 757 - 763.
[Full Text] [PDF]

Home page
 J Intensive Care MedHome page
D. J. Costello and A. J. Cole
Treatment of Acute Seizures and Status Epilepticus
J Intensive Care Med, November 1, 2007; 22(6): 319 - 347.
[Abstract] [PDF]

Home page
 J Child NeurolHome page
V. Mehta, P. Singhi, and S. Singhi
Intravenous Sodium Valproate Versus Diazepam Infusion for the Control of Refractory Status Epilepticus in Children: A Randomized Controlled Trial
J Child Neurol, October 1, 2007; 22(10): 1191 - 1197.
[Abstract] [PDF]

Home page
 NeurologyHome page
A. O. Rossetti, U .K. Misra, J . Kalita, and R . Patel
Sodium valproate vs phenytoin in status epilepticus: A pilot study
Neurology, February 27, 2007; 68(9): 709 - 709.
[Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
S. Baltes, M. Fedrowitz, C. L. Tortos, H. Potschka, and W. Loscher
Valproic Acid Is Not a Substrate for P-glycoprotein or Multidrug Resistance Proteins 1 and 2 in a Number of in Vitro and in Vivo Transport Assays
J. Pharmacol. Exp. Ther., January 1, 2007; 320(1): 331 - 343.
[Abstract] [Full Text] [PDF]

Home page
 Postgrad. Med. J.Home page
R Nandhagopal
Generalised convulsive status epilepticus: an overview
Postgrad. Med. J., November 1, 2006; 82(973): 723 - 732.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
U. K. Misra, J. Kalita, and R. Patel
Sodium valproate vs phenytoin in status epilepticus: a pilot study.
Neurology, July 25, 2006; 67(2): 340 - 342.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
A. O. Rossetti, E. B. Bromfield, N. A. Limdi, E. Faught, and J. Burneo
Efficacy of rapid IV administration of valproic acid for status epilepticus
Neurology, August 9, 2005; 65(3): 500 - 501.
[Full Text] [PDF]

Correspondence:

Read all Correspondence

Efficacy of rapid IV administration of valproic acid for status epilepticus
Andrea O. Rossetti, et al.
Neurology Online, 15 Mar 2005 [Full text]
Reply to Rossetti et al
Nita A Limdi, et al.
Neurology Online, 15 Mar 2005 [Full text]

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by AAN Enterprises, Inc.